Your browser doesn't support javascript.
loading
Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study.
Montalescot, Gilles; Collet, Jean-Philippe; Ecollan, Patrick; Bolognese, Leonardo; Ten Berg, Jurrien; Dudek, Dariusz; Hamm, Christian; Widimsky, Petr; Tanguay, Jean-François; Goldstein, Patrick; Brown, Eileen; Miller, Debra L; LeNarz, LeRoy; Vicaut, Eric.
Afiliação
  • Montalescot G; ACTION Study Group, Institut de Cardiologie, UPMC Université Paris 6, INSERM UMRS-1166 Paris, Centre Hospitalier Universitaire Pitié-Salpêtriere (AP-HP), Paris, France. Electronic address: gilles.montalescot@psl.aphp.fr.
  • Collet JP; ACTION Study Group, Institut de Cardiologie, UPMC Université Paris 6, INSERM UMRS-1166 Paris, Centre Hospitalier Universitaire Pitié-Salpêtriere (AP-HP), Paris, France.
  • Ecollan P; ACTION Study Group, SMUR, Centre Hospitalier Universitaire Pitié-Salpêtriere (AP-HP), Paris, France.
  • Bolognese L; Cardiovascular and Neurological Department, Azienda Ospedaliera, Arezzo, Italy.
  • Ten Berg J; Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.
  • Dudek D; Institute of Cardiology, Jagiellonian University Medical College, University Hospital, Krakow, Poland.
  • Hamm C; Kerckhoff Heart and Thoraxcenter, Bad Nauheim and Medical Clinic I, University of Giessen, Giessen, Germany.
  • Widimsky P; Third Medical Faculty of Charles University and University Hospital Royal Vineyards, Prague, Czech Republic.
  • Tanguay JF; Montreal Heart Institute, Montreal, Quebec, Canada.
  • Goldstein P; SAMU and Emergency Department, Lille University Hospital, Lille, France.
  • Brown E; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
  • Miller DL; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
  • LeNarz L; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
  • Vicaut E; ACTION Study Group, Methodology and Statistical Unit, Centre Hospitalier Universitaire Lariboisière (AP-HP), Université Paris 7, Paris, France.
J Am Coll Cardiol ; 64(24): 2563-2571, 2014 Dec 23.
Article em En | MEDLINE | ID: mdl-25524333
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Tiofenos / Intervenção Coronária Percutânea / Hemorragia / Complicações Intraoperatórias / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2014 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Tiofenos / Intervenção Coronária Percutânea / Hemorragia / Complicações Intraoperatórias / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2014 Tipo de documento: Article País de publicação: Estados Unidos